#osteoporosis
Latest news and interesting information about osteoporosis.
Entera Bio Presents Clinical Data on Osteoporosis Drug
Entera Bio presents clinical data for osteoporosis drug EB613. Presentation at ENDO 2026 conference.
Bernstein Initiates Neurocrine with Outperform Rating
Bernstein initiates Neurocrine Biosciences with an outperform rating and $221 price target. Highlights Crenessity's potential and stock upside.
Age Factor in Bone Trauma: Risk for Children?
Information on the age factor in bone trauma. Differences in fracture healing between children and adults.
New Discovery in Arthritis and Osteoporosis Treat
A new synthetic method for curculigoside A, a compound for arthritis and osteoporosis treatment, achieved 90% efficiency by TPU and Swedish scientists.
...